ArticleFrontiers in psychiatry2025
Treatment-resistant or difficult-to-treat depression: a consensus on the pharmacotherapy challenges and considerations for the health care system in Greece.
Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A critical appraisal of integrating family constellation therapy with pharmacological treatment for depression.Frontiers in psychiatry · 2026Review
- Case Report: Application of accelerated continuous theta burst stimulation in treatment-resistant depression.Frontiers in psychiatry · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Globally, there is limited scientific consensus on the definition of Treatment Resistant Depression (TRD) or Difficult to Treat Depression (DTD) and even greater challenges are being reported with its management. In Greece, the last available guidelines on depression from 2015 make no reference to TRD/DTD management. This study aims to inform the definition of TRD or DTD and propose a pathway for its integrated management in the context of the Greek National Health System (NHS). Methods: Individual interviews with clinical experts based on a structured interview guide were conducted in November 2022 to explore consensus on the definition, key challenges, and prospects for the management of TRD/DTD in Greece. Results were combined in a manuscript that was circulated amongst authors for comments and sign off. Results: Participants preferred the use of the DTD term over TRD, though noted that using the term TRD may be more amendable to wider scientific audiences. They also agreed on the need to set bold treatment goals and assess optimal treatment dose, duration, and adherence, in the context of shared decision making, prior to confirming a diagnosis as TRD/DTD and proposing a treatment strategy. Integration of patient management with use of mobile mental health units, Mental Health Centers and tertiary Centers of Excellence would promote patient centricity, accessibility, affordability as well as help develop an evidence basis for the further customization and evolution of mental health policies in the future. Conclusion: This is the first study to discuss and define the challenge of TRD/DTD in Greece and propose a structured pathway for its integrated management in the context of the Greek NHS, allowing for the country's geographic disparities, history of burden of mental health and socioeconomic specificities, including stigma surrounding a mental health diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.